-
1
-
-
0034133548
-
Idiopathic pulmonary fibrosis: Diagnosis and treatment; joint statement of the American Thoracic Society and the European Respiratory Society
-
American Thoracic Society
-
Idiopathic pulmonary fibrosis: Diagnosis and treatment; joint statement of the American Thoracic Society and the European Respiratory Society. Am J Respir Crit Care Med 2000, 161:646-664. American Thoracic Society.
-
(2000)
Am J Respir Crit Care Med
, vol.161
, pp. 646-664
-
-
-
2
-
-
79952717349
-
An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management
-
Raghu G., Collard H.R., Egan J.J., Martinez F.J., Behr J., Brown K.K., et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183:788-824.
-
(2011)
Am J Respir Crit Care Med
, vol.183
, pp. 788-824
-
-
Raghu, G.1
Collard, H.R.2
Egan, J.J.3
Martinez, F.J.4
Behr, J.5
Brown, K.K.6
-
3
-
-
0346271814
-
Diagnóstico y tratamiento de las enfermedades pulmonares intersticiales difusas
-
Xaubet A., Ancochea J., Blanquer R., Montero C., Morell F., Rodríguez Becerra E., et al. Diagnóstico y tratamiento de las enfermedades pulmonares intersticiales difusas. Arch Bronconeumol 2003, 39:580-600.
-
(2003)
Arch Bronconeumol
, vol.39
, pp. 580-600
-
-
Xaubet, A.1
Ancochea, J.2
Blanquer, R.3
Montero, C.4
Morell, F.5
Rodríguez Becerra, E.6
-
4
-
-
33748305617
-
An official ATS statement: Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations
-
Schünemann H.J., Jaeschke R., Cook D.J., Bria W.F., El-Solh A.A., Ernst A., et al. An official ATS statement: Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006, 174:605-614.
-
(2006)
Am J Respir Crit Care Med
, vol.174
, pp. 605-614
-
-
Schünemann, H.J.1
Jaeschke, R.2
Cook, D.J.3
Bria, W.F.4
El-Solh, A.A.5
Ernst, A.6
-
5
-
-
33749444308
-
Incidence and prevalence of idiopathic pulmonary fibrosis
-
Raghu G., Weycker D., Edelsberg J., Bradford W.Z., Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006, 174:810-816.
-
(2006)
Am J Respir Crit Care Med
, vol.174
, pp. 810-816
-
-
Raghu, G.1
Weycker, D.2
Edelsberg, J.3
Bradford, W.Z.4
Oster, G.5
-
6
-
-
79956343961
-
The rising incidence of idiopathic pulmonary fibrosis in the UK
-
Navaratnam V., Fleming K.M., West J., Smith C.J., Jenkins R.G., Fogarty A., et al. The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax 2011, 66:462-467.
-
(2011)
Thorax
, vol.66
, pp. 462-467
-
-
Navaratnam, V.1
Fleming, K.M.2
West, J.3
Smith, C.J.4
Jenkins, R.G.5
Fogarty, A.6
-
7
-
-
37549060070
-
Accelerated variant of idiopathic pulmonary fibrosis
-
Selman M., Carrillo G., Estrada A., Mejia M., Becerril C., Cisneros J., et al. Accelerated variant of idiopathic pulmonary fibrosis. PLos ONE 2007, 2:e482.
-
(2007)
PLos ONE
, vol.2
-
-
Selman, M.1
Carrillo, G.2
Estrada, A.3
Mejia, M.4
Becerril, C.5
Cisneros, J.6
-
8
-
-
84865832642
-
The genetics and environmental causes of pulmonary fibrosis
-
Mcneal K., Schwartz D.A. The genetics and environmental causes of pulmonary fibrosis. Proc Am Thorac Soc 2012, 9:120-125.
-
(2012)
Proc Am Thorac Soc
, vol.9
, pp. 120-125
-
-
Mcneal, K.1
Schwartz, D.A.2
-
9
-
-
79955146233
-
A common MUC5B promoter polymorphism and pulmonary fibrosis
-
Seibod M.A., Wise A.L., Speer M.C., Steele M.P., Brown K.K., Loyd J.E., et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 2011, 364:1503-1512.
-
(2011)
N Engl J Med
, vol.364
, pp. 1503-1512
-
-
Seibod, M.A.1
Wise, A.L.2
Speer, M.C.3
Steele, M.P.4
Brown, K.K.5
Loyd, J.E.6
-
10
-
-
43449105048
-
Occupational risks for idiopathic pulmonary fibrosis mortality in the United States
-
Pinheiro G.A., Antao V.C., Wood J.M., Wassell J.T. Occupational risks for idiopathic pulmonary fibrosis mortality in the United States. Int J Occup Environ Health 2008, 14:117-123.
-
(2008)
Int J Occup Environ Health
, vol.14
, pp. 117-123
-
-
Pinheiro, G.A.1
Antao, V.C.2
Wood, J.M.3
Wassell, J.T.4
-
11
-
-
33744908816
-
Is idiopathic pulmonary fibrosis an environmental disease?
-
Taskar V.S., Coultas D.B. Is idiopathic pulmonary fibrosis an environmental disease?. Proc Am Thorac Soc 2006, 3:293-298.
-
(2006)
Proc Am Thorac Soc
, vol.3
, pp. 293-298
-
-
Taskar, V.S.1
Coultas, D.B.2
-
12
-
-
84455201657
-
Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis
-
Lee J.S., Ryu J.H., Elicker B.M., Lydell C.P., Jones K.D., Wolters P.J., et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011, 184:1390-1394.
-
(2011)
Am J Respir Crit Care Med
, vol.184
, pp. 1390-1394
-
-
Lee, J.S.1
Ryu, J.H.2
Elicker, B.M.3
Lydell, C.P.4
Jones, K.D.5
Wolters, P.J.6
-
13
-
-
34248372493
-
Idiopathic interstitial pneumonia: Do community and academic physicians agree on diagnosis?
-
Flaherty K.R., Andrei A.C., King T.E., Raghu G., Colby T.V., Wells A., et al. Idiopathic interstitial pneumonia: Do community and academic physicians agree on diagnosis?. Am J Respir Crit Care Med 2007, 175:1054-1060.
-
(2007)
Am J Respir Crit Care Med
, vol.175
, pp. 1054-1060
-
-
Flaherty, K.R.1
Andrei, A.C.2
King, T.E.3
Raghu, G.4
Colby, T.V.5
Wells, A.6
-
14
-
-
33744916992
-
Classification and natural history of the idiopathic interstitial pneumonias
-
Kim D.S., Collard H.R., King T.E. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006, 3:285-292.
-
(2006)
Proc Am Thorac Soc
, vol.3
, pp. 285-292
-
-
Kim, D.S.1
Collard, H.R.2
King, T.E.3
-
15
-
-
43249084804
-
MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis
-
0623-0633
-
Rosas I.O., Richards T.J., Konishi K., Zhang Y., Gibson K., Lokshin A.E., et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 2008, 5:e93. 0623-0633.
-
(2008)
PLoS Med
, vol.5
-
-
Rosas, I.O.1
Richards, T.J.2
Konishi, K.3
Zhang, Y.4
Gibson, K.5
Lokshin, A.E.6
-
16
-
-
0036469096
-
Comparative study of KL-6, surfactant protein-A, surfactantprotein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases
-
Ohnishi H., Yokoyama A., Kondo K., Zhang Y., Gibson K., Lokshin S.F., et al. Comparative study of KL-6, surfactant protein-A, surfactantprotein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Resp Crit Care Med 2002, 165:378-381.
-
(2002)
Am J Resp Crit Care Med
, vol.165
, pp. 378-381
-
-
Ohnishi, H.1
Yokoyama, A.2
Kondo, K.3
Zhang, Y.4
Gibson, K.5
Lokshin, S.F.6
-
17
-
-
65249098301
-
Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis
-
Moeller A., Gilpin S.E., Ask K., Cox G., Cook D., Gauldie J., et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Resp Crit Care Med 2009, 179:588-594.
-
(2009)
Am J Resp Crit Care Med
, vol.179
, pp. 588-594
-
-
Moeller, A.1
Gilpin, S.E.2
Ask, K.3
Cox, G.4
Cook, D.5
Gauldie, J.6
-
19
-
-
33847664321
-
Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease
-
Leslie K.O., Gruden J.F., Parish J.M., Scholand M.B. Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch Pathol Lab Med 2007, 131:407-423.
-
(2007)
Arch Pathol Lab Med
, vol.131
, pp. 407-423
-
-
Leslie, K.O.1
Gruden, J.F.2
Parish, J.M.3
Scholand, M.B.4
-
20
-
-
68549125418
-
Transbronchial cryobiopsy: A new tool for lung biopsies
-
Babiak A., Hetzel J., Krishna G., Fritz P., Moeller P., Balli T., et al. Transbronchial cryobiopsy: A new tool for lung biopsies. Respiration 2009, 78:203-208.
-
(2009)
Respiration
, vol.78
, pp. 203-208
-
-
Babiak, A.1
Hetzel, J.2
Krishna, G.3
Fritz, P.4
Moeller, P.5
Balli, T.6
-
21
-
-
0038037974
-
Radiation exposure at chest CT: A statement of the Fleischner Society
-
Mayo J.R., Aldrich J., Muller N.L. Radiation exposure at chest CT: A statement of the Fleischner Society. Radiology 2003, 228:15-21.
-
(2003)
Radiology
, vol.228
, pp. 15-21
-
-
Mayo, J.R.1
Aldrich, J.2
Muller, N.L.3
-
22
-
-
40949159721
-
Fleischner Society: Glossary of terms for thoracic imaging
-
Hansell D.M., Bankier A.A., MacMahon H., McLoud T.C., Muller N.L., Remy J. Fleischner Society: Glossary of terms for thoracic imaging. Radiology 2008, 246:697-722.
-
(2008)
Radiology
, vol.246
, pp. 697-722
-
-
Hansell, D.M.1
Bankier, A.A.2
MacMahon, H.3
McLoud, T.C.4
Muller, N.L.5
Remy, J.6
-
23
-
-
33645214049
-
Chronic hypersensitivity pneumonitis
-
Churg A., Müller N.L., Flint J., Wright J.L. Chronic hypersensitivity pneumonitis. Am J Surg Pathol 2006, 30:201-208.
-
(2006)
Am J Surg Pathol
, vol.30
, pp. 201-208
-
-
Churg, A.1
Müller, N.L.2
Flint, J.3
Wright, J.L.4
-
24
-
-
0021256105
-
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical index
-
Mahler D.A., Weinberg D.H., Wells C.K., Feinstein A.R. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical index. Chest 1984, 85:751-758.
-
(1984)
Chest
, vol.85
, pp. 751-758
-
-
Mahler, D.A.1
Weinberg, D.H.2
Wells, C.K.3
Feinstein, A.R.4
-
25
-
-
78349286777
-
A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis
-
Nishiyama O., Taniguchi H., Konodoh Y., Kimura T., Kato K., Kataoka K., et al. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J 2010, 36:1067-1072.
-
(2010)
Eur Respir J
, vol.36
, pp. 1067-1072
-
-
Nishiyama, O.1
Taniguchi, H.2
Konodoh, Y.3
Kimura, T.4
Kato, K.5
Kataoka, K.6
-
26
-
-
0037383035
-
Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)
-
Birring S.S., Pruden B., Carr A.J., Singh S.J., Morgan M.D.L., Pavord I.D. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003, 58:339-343.
-
(2003)
Thorax
, vol.58
, pp. 339-343
-
-
Birring, S.S.1
Pruden, B.2
Carr, A.J.3
Singh, S.J.4
Morgan, M.D.L.5
Pavord, I.D.6
-
27
-
-
77957202563
-
Development and validity testing of an IPF-specific version of the St George's respiratory questionnaire
-
Yorke J., Jones P.W., Swigris J.J. Development and validity testing of an IPF-specific version of the St George's respiratory questionnaire. Thorax 2010, 65:921-926.
-
(2010)
Thorax
, vol.65
, pp. 921-926
-
-
Yorke, J.1
Jones, P.W.2
Swigris, J.J.3
-
28
-
-
79951844263
-
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
-
Ley B., Collard H.R., King T.E. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011, 183:431-440.
-
(2011)
Am J Respir Crit Care Med
, vol.183
, pp. 431-440
-
-
Ley, B.1
Collard, H.R.2
King, T.E.3
-
29
-
-
84863490896
-
Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: A 3-year prospective study
-
Mura M., Porretta M.A., Bargagli E., Sergiacomi G., Zompatori M., Sverzellati N., et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: A 3-year prospective study. Eur Respir J 2012, 40:101-109.
-
(2012)
Eur Respir J
, vol.40
, pp. 101-109
-
-
Mura, M.1
Porretta, M.A.2
Bargagli, E.3
Sergiacomi, G.4
Zompatori, M.5
Sverzellati, N.6
-
30
-
-
79960426037
-
Long-term curse and prognosis of idiopathic pulmonary fibrosis in the new millennium
-
Nathan S.D., Shlobin O.A., Weir N. Long-term curse and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest 2011, 140:21-229.
-
(2011)
Chest
, vol.140
, pp. 21-229
-
-
Nathan, S.D.1
Shlobin, O.A.2
Weir, N.3
-
31
-
-
84455168726
-
Forced vital capacity in patients with idiopathic pulmonary fibrosis: Test properties and minimal clinically important difference
-
Du Bois R.M., Weycker D., Albera C., Bradford W.Z., Costabel U., Kartashov A., et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: Test properties and minimal clinically important difference. Am J Respir Crit Care Med 2011, 184:1382-1389.
-
(2011)
Am J Respir Crit Care Med
, vol.184
, pp. 1382-1389
-
-
Du Bois, R.M.1
Weycker, D.2
Albera, C.3
Bradford, W.Z.4
Costabel, U.5
Kartashov, A.6
-
32
-
-
79960193484
-
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
-
Schmidt S.L., Nambiar A.M., Tayab N., Sundaram B., Han M.K., Gross B.H., et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J 2011, 38:176-183.
-
(2011)
Eur Respir J
, vol.38
, pp. 176-183
-
-
Schmidt, S.L.1
Nambiar, A.M.2
Tayab, N.3
Sundaram, B.4
Han, M.K.5
Gross, B.H.6
-
33
-
-
79955520497
-
Six-minute-walk test in idiopathic pulmonary fibrosis: Test validation and minimal clinically important difference
-
Du Bois R.M., Weycker D., Albera C., Bradford W.Z., Costabel U., Kastashou A., et al. Six-minute-walk test in idiopathic pulmonary fibrosis: Test validation and minimal clinically important difference. Am J Respir Crit Care Med 2011, 183:1231-1237.
-
(2011)
Am J Respir Crit Care Med
, vol.183
, pp. 1231-1237
-
-
Du Bois, R.M.1
Weycker, D.2
Albera, C.3
Bradford, W.Z.4
Costabel, U.5
Kastashou, A.6
-
34
-
-
33749434364
-
Idiopathic pulmonary fibrosis: Prognostic value of changes in physiology and six-minute-walk test
-
Flaherty K.R., Andrei A.C., Murray S., Fraley C., Colby T.V., Travis W.D., et al. Idiopathic pulmonary fibrosis: Prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 2006, 17:803-809.
-
(2006)
Am J Respir Crit Care Med
, vol.17
, pp. 803-809
-
-
Flaherty, K.R.1
Andrei, A.C.2
Murray, S.3
Fraley, C.4
Colby, T.V.5
Travis, W.D.6
-
35
-
-
63349091740
-
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis
-
Fell C.D., Liu L.X., Motika C., Kazerooni E.A., Gross B.H., Travis W.D., et al. The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009, 179:402-407.
-
(2009)
Am J Respir Crit Care Med
, vol.179
, pp. 402-407
-
-
Fell, C.D.1
Liu, L.X.2
Motika, C.3
Kazerooni, E.A.4
Gross, B.H.5
Travis, W.D.6
-
36
-
-
39849111240
-
Computed tomography findings in pathological usual interstitial pneumonia: Relationship to survival
-
Sumikawa H., Johkoh T., Colby T.V., Ichikado K., Suga M., Taniguchi H., et al. Computed tomography findings in pathological usual interstitial pneumonia: Relationship to survival. Am J Respir Crit Care Med 2008, 177:433-439.
-
(2008)
Am J Respir Crit Care Med
, vol.177
, pp. 433-439
-
-
Sumikawa, H.1
Johkoh, T.2
Colby, T.V.3
Ichikado, K.4
Suga, M.5
Taniguchi, H.6
-
37
-
-
84855264195
-
Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis
-
Richards T.J., Kaminski N., Baribaud F., Flavin S., Brodmerkel C., Horowitz D., et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012, 185:67-76.
-
(2012)
Am J Respir Crit Care Med
, vol.185
, pp. 67-76
-
-
Richards, T.J.1
Kaminski, N.2
Baribaud, F.3
Flavin, S.4
Brodmerkel, C.5
Horowitz, D.6
-
38
-
-
33645297106
-
Brain natriuretic peptide is a prognostic parameter in chronic lung disease
-
Leuchte H.H., Baumgartner R.A., Nounou M.E., Vogeser M., Neurohr C., Trautnitz M., et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006, 173:744-750.
-
(2006)
Am J Respir Crit Care Med
, vol.173
, pp. 744-750
-
-
Leuchte, H.H.1
Baumgartner, R.A.2
Nounou, M.E.3
Vogeser, M.4
Neurohr, C.5
Trautnitz, M.6
-
39
-
-
80051819865
-
Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis
-
Du Bois R.M., Weycker D., Albera C., Bradford W.Z., Costabel U., Kartashov A., et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011, 184:459-466.
-
(2011)
Am J Respir Crit Care Med
, vol.184
, pp. 459-466
-
-
Du Bois, R.M.1
Weycker, D.2
Albera, C.3
Bradford, W.Z.4
Costabel, U.5
Kartashov, A.6
-
40
-
-
84861162888
-
A multidimensional index and staging system for idiopathic pulmonary fibrosis
-
Ley B., Ryerson C.J., Vittinghoff E., Ryu J.H., Tomasetti S., Lee J.S., et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 2012, 156:684-691.
-
(2012)
Ann Intern Med
, vol.156
, pp. 684-691
-
-
Ley, B.1
Ryerson, C.J.2
Vittinghoff, E.3
Ryu, J.H.4
Tomasetti, S.5
Lee, J.S.6
-
41
-
-
84863134839
-
Acute exacerbation of idiopathic pulmonary fibrosis
-
Kim D.S. Acute exacerbation of idiopathic pulmonary fibrosis. Clin Chest Med 2012, 33:59-68.
-
(2012)
Clin Chest Med
, vol.33
, pp. 59-68
-
-
Kim, D.S.1
-
42
-
-
84863438783
-
Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
-
Judge E.P., Fabre A., Adamali H.I., Egan J.J. Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Eur Respir J 2012, 40:93-100.
-
(2012)
Eur Respir J
, vol.40
, pp. 93-100
-
-
Judge, E.P.1
Fabre, A.2
Adamali, H.I.3
Egan, J.J.4
-
43
-
-
84865588568
-
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
-
Nathan S.D., Cottin V. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Eur Respir Monogr 2012, 57:148-160.
-
(2012)
Eur Respir Monogr
, vol.57
, pp. 148-160
-
-
Nathan, S.D.1
Cottin, V.2
-
44
-
-
33645118315
-
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
-
Lettieri C.J., Nathan S.D., Barnett S.D., Ahmad S., Shorr A. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006, 3:746-752.
-
(2006)
Chest
, vol.3
, pp. 746-752
-
-
Lettieri, C.J.1
Nathan, S.D.2
Barnett, S.D.3
Ahmad, S.4
Shorr, A.5
-
45
-
-
70349673627
-
Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension
-
Corte T.J., Wort S.J., Gatzoulis M.A., Macdonald P., Hansell D.M., Wells A.U. Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension. Thorax 2009, 64:883-888.
-
(2009)
Thorax
, vol.64
, pp. 883-888
-
-
Corte, T.J.1
Wort, S.J.2
Gatzoulis, M.A.3
Macdonald, P.4
Hansell, D.M.5
Wells, A.U.6
-
46
-
-
84855471916
-
Combined pulmonary fibrosis and emphysema syndrome: A review
-
Jankowich M.D., Rounds S.I.S. Combined pulmonary fibrosis and emphysema syndrome: A review. Chest 2012, 141:222-231.
-
(2012)
Chest
, vol.141
, pp. 222-231
-
-
Jankowich, M.D.1
Rounds, S.I.S.2
-
47
-
-
84856743162
-
Silent gastro-esophageal reflux and microaspiration in IPF: Mounting evidence for anti-reflux therapy
-
Raghu G., Meyer K.C. Silent gastro-esophageal reflux and microaspiration in IPF: Mounting evidence for anti-reflux therapy. Eur Respir J 2012, 39:242-245.
-
(2012)
Eur Respir J
, vol.39
, pp. 242-245
-
-
Raghu, G.1
Meyer, K.C.2
-
48
-
-
70049102004
-
Obstructive sleep apnea is common in idiopathic pulmonary fibrosis
-
Lancaster L.H., Mason W.R., Parnell J.A., Rice T.W., Loyd J.E., Milstone A.P., et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 2009, 136:772-778.
-
(2009)
Chest
, vol.136
, pp. 772-778
-
-
Lancaster, L.H.1
Mason, W.R.2
Parnell, J.A.3
Rice, T.W.4
Loyd, J.E.5
Milstone, A.P.6
-
49
-
-
68249127904
-
Cumulative incidence of and predictive factors for lung cancer in IPF
-
Ozawa Y., Suda T., Naito T., Enomoto N., Hashimoto D., Fujisawa T., et al. Cumulative incidence of and predictive factors for lung cancer in IPF. Respirology 2009, 14:723-728.
-
(2009)
Respirology
, vol.14
, pp. 723-728
-
-
Ozawa, Y.1
Suda, T.2
Naito, T.3
Enomoto, N.4
Hashimoto, D.5
Fujisawa, T.6
-
50
-
-
57149114526
-
The association between idiopathic pulmonary fibrosis and vascular disease: A population-based study
-
Hubbard R.B., Smith C., le Jeune I., Gribbin J., Fogarty A.W. The association between idiopathic pulmonary fibrosis and vascular disease: A population-based study. Am J Respir Crit Care Med 2008, 178:1257-1261.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, pp. 1257-1261
-
-
Hubbard, R.B.1
Smith, C.2
le Jeune, I.3
Gribbin, J.4
Fogarty, A.W.5
-
51
-
-
80051795063
-
Comprehensive care of the patient with idiopathic pulmonary fibrosis
-
Lee J.S., McLaughlin S., Collard H.R. Comprehensive care of the patient with idiopathic pulmonary fibrosis. Curr Opin Pulm Med 2011, 17:348-354.
-
(2011)
Curr Opin Pulm Med
, vol.17
, pp. 348-354
-
-
Lee, J.S.1
McLaughlin, S.2
Collard, H.R.3
-
54
-
-
77957957648
-
Non-steroid agents for idiopathic pulmonary fibrosis
-
Spagnolo P., del Giovane C., Luppi F., Cerri S., Balduzzi S., Walter E.R., et al. Non-steroid agents for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev 2010, 9:CD003134.
-
(2010)
Cochrane Database Syst Rev
, vol.9
-
-
Spagnolo, P.1
del Giovane, C.2
Luppi, F.3
Cerri, S.4
Balduzzi, S.5
Walter, E.R.6
-
55
-
-
28144459814
-
High-dose acetylcysteine in idiopathic pulmonary fibrosis
-
Demedts M., Behr J., Buhl R., Costabel U., Dekhuijzen R., Jansen H.M., et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005, 353:2229-2242.
-
(2005)
N Engl J Med
, vol.353
, pp. 2229-2242
-
-
Demedts, M.1
Behr, J.2
Buhl, R.3
Costabel, U.4
Dekhuijzen, R.5
Jansen, H.M.6
-
56
-
-
84861394764
-
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis
-
Idiopathic Pulmonary Fibrosis Clinical Research Network
-
Raghu G., Anstrom K.J., King T.E., Lasky J.A., Martinez F.J. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012, 366:1968-1977. Idiopathic Pulmonary Fibrosis Clinical Research Network.
-
(2012)
N Engl J Med
, vol.366
, pp. 1968-1977
-
-
Raghu, G.1
Anstrom, K.J.2
King, T.E.3
Lasky, J.A.4
Martinez, F.J.5
-
57
-
-
84861840824
-
Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes
-
Cottin V. Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes. Eur Respir Rev 2012, 21:161-167.
-
(2012)
Eur Respir Rev
, vol.21
, pp. 161-167
-
-
Cottin, V.1
-
58
-
-
79956341531
-
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials
-
Noble P.W., Albera C., Bradford W.Z., Costabel U., Glassberg M.K., Kardatzke D., et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials. Lancet 2011, 377:1760-1769.
-
(2011)
Lancet
, vol.377
, pp. 1760-1769
-
-
Noble, P.W.1
Albera, C.2
Bradford, W.Z.3
Costabel, U.4
Glassberg, M.K.5
Kardatzke, D.6
-
59
-
-
77951160564
-
Pirfenidone in idiopathic pulmonary fibrosis
-
Taniguchi H., Ebina M., Kondoh Y., Azuma A., Ogura T., Taguchi Y., et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 2010, 35:1079-1087.
-
(2010)
Eur Respir J
, vol.35
, pp. 1079-1087
-
-
Taniguchi, H.1
Ebina, M.2
Kondoh, Y.3
Azuma, A.4
Ogura, T.5
Taguchi, Y.6
-
60
-
-
84867320020
-
Adverse events of pirfenidone for the treatment of pulmonary fibrosis: A meta-analysis of randomized controlled trials
-
Jiang C., Huang H., Liu J., Wang Y., Lu Z., Xu Z. Adverse events of pirfenidone for the treatment of pulmonary fibrosis: A meta-analysis of randomized controlled trials. PLoS One 2012, 7:e47024.
-
(2012)
PLoS One
, vol.7
-
-
Jiang, C.1
Huang, H.2
Liu, J.3
Wang, Y.4
Lu, Z.5
Xu, Z.6
-
61
-
-
80053091084
-
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis
-
Richeldi L., Costabel U., Selman M., Kim D.S., Hansell D.M., Nicholson A.G., et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 2011, 365:1079-1087.
-
(2011)
N Engl J Med
, vol.365
, pp. 1079-1087
-
-
Richeldi, L.1
Costabel, U.2
Selman, M.3
Kim, D.S.4
Hansell, D.M.5
Nicholson, A.G.6
-
62
-
-
84864872340
-
The big clinical trials in idiopathic pulmonary fibrosis
-
Luppi F., Spagnolo P., Cerri S., Richeldi L. The big clinical trials in idiopathic pulmonary fibrosis. Curr Opin Pulm 2012, 18:428-432.
-
(2012)
Curr Opin Pulm
, vol.18
, pp. 428-432
-
-
Luppi, F.1
Spagnolo, P.2
Cerri, S.3
Richeldi, L.4
-
63
-
-
34848821215
-
Acute exacerbations of idiopathic pulmonary fibrosis
-
Collard H.R., Moore B., Flaherty K., Brown K., Kaner R.J., King T.E., et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007, 176:636-647.
-
(2007)
Am J Respir Crit Care Med
, vol.176
, pp. 636-647
-
-
Collard, H.R.1
Moore, B.2
Flaherty, K.3
Brown, K.4
Kaner, R.J.5
King, T.E.6
-
64
-
-
76749146423
-
Mechanical ventilation in patients with end-stage idiopathic pulmonary fibrosis
-
Mollica C., Paone G., Conti V., Ceccarelli D., Schmid G., Mattia P., et al. Mechanical ventilation in patients with end-stage idiopathic pulmonary fibrosis. Respiration 2010, 79:209-215.
-
(2010)
Respiration
, vol.79
, pp. 209-215
-
-
Mollica, C.1
Paone, G.2
Conti, V.3
Ceccarelli, D.4
Schmid, G.5
Mattia, P.6
-
65
-
-
0038383219
-
Resultados y características clínicas de los pacientes con fibrosis pulmonar e insuficiencia respiratoria ingresados en una Unidad de Cuidados Intensivos. Estudio de 20 casos
-
Molina-Molina M., Badia J.R., Marín-Arguedas A., Xaubet A., Santos M.J., Nicolás J.M., et al. Resultados y características clínicas de los pacientes con fibrosis pulmonar e insuficiencia respiratoria ingresados en una Unidad de Cuidados Intensivos. Estudio de 20 casos. Med Clin (Barc) 2003, 121:63-67.
-
(2003)
Med Clin (Barc)
, vol.121
, pp. 63-67
-
-
Molina-Molina, M.1
Badia, J.R.2
Marín-Arguedas, A.3
Xaubet, A.4
Santos, M.J.5
Nicolás, J.M.6
-
66
-
-
33947386257
-
Sildefanil improves walk distance in idiopathic pulmonary fibrosis
-
Collard H.R., Anstrom J.K., Schwarz M.I., Zisman D.A. Sildefanil improves walk distance in idiopathic pulmonary fibrosis. Chest 2007, 131:897-899.
-
(2007)
Chest
, vol.131
, pp. 897-899
-
-
Collard, H.R.1
Anstrom, J.K.2
Schwarz, M.I.3
Zisman, D.A.4
-
67
-
-
80051790295
-
Pulmonary hypertension in idiopathic pulmonary fibrosis: A review
-
Pitsiou G., Papakosta D., Bouros D. Pulmonary hypertension in idiopathic pulmonary fibrosis: A review. Respiration 2011, 82:294-304.
-
(2011)
Respiration
, vol.82
, pp. 294-304
-
-
Pitsiou, G.1
Papakosta, D.2
Bouros, D.3
-
69
-
-
80053546180
-
Ambulatory oxygen in interstitial lung disease
-
Visca D., Montgomery A., de Lauretis A., Sestini P., Soteriou H., Maher T.M., et al. Ambulatory oxygen in interstitial lung disease. Eur Respir J 2011, 38:987-990.
-
(2011)
Eur Respir J
, vol.38
, pp. 987-990
-
-
Visca, D.1
Montgomery, A.2
de Lauretis, A.3
Sestini, P.4
Soteriou, H.5
Maher, T.M.6
-
70
-
-
84863453754
-
Ambulatory oxygen in idiopathic pulmonary fibrosis: Of what benefit?
-
Frank R.C., Hicks S., Duck A.M., Spencer L., Leonard C.T., Barnett E. Ambulatory oxygen in idiopathic pulmonary fibrosis: Of what benefit?. Eur Respir J 2012, 40:269-270.
-
(2012)
Eur Respir J
, vol.40
, pp. 269-270
-
-
Frank, R.C.1
Hicks, S.2
Duck, A.M.3
Spencer, L.4
Leonard, C.T.5
Barnett, E.6
-
71
-
-
84856693618
-
Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis
-
Hook J.L., Arcosoy S.M., Zemmel D., Bartels M.N., Kawut S.M., Lederer D.J. Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis. Eur Respir J 2012, 39:359-365.
-
(2012)
Eur Respir J
, vol.39
, pp. 359-365
-
-
Hook, J.L.1
Arcosoy, S.M.2
Zemmel, D.3
Bartels, M.N.4
Kawut, S.M.5
Lederer, D.J.6
-
72
-
-
80054736643
-
Lung transplant in idiopathic pulmonary fibrosis
-
George T.J., Arnaoutakis G.J., Shah A.S. Lung transplant in idiopathic pulmonary fibrosis. Arch Surg 2011, 146:1204-1209.
-
(2011)
Arch Surg
, vol.146
, pp. 1204-1209
-
-
George, T.J.1
Arnaoutakis, G.J.2
Shah, A.S.3
-
74
-
-
84855867125
-
Predictors of benefit following pulmonary rehabilitation for interstitial lung disease
-
Holland A.E., Hill C.J., Glaspone I., Goh N., McDonald C.F. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir Med 2012, 106:429-435.
-
(2012)
Respir Med
, vol.106
, pp. 429-435
-
-
Holland, A.E.1
Hill, C.J.2
Glaspone, I.3
Goh, N.4
McDonald, C.F.5
-
75
-
-
84871339379
-
Effects of in-patient pulmonary rehabilitation in patients with interstitial lung disease
-
(Epub ahead of print)
-
Huppmann P., Sczepanski B., Boensch M., Winterkmp S., Schönheit-Kenn U., Neurohr C., et al. Effects of in-patient pulmonary rehabilitation in patients with interstitial lung disease. Eur Respir J 2012, (Epub ahead of print).
-
(2012)
Eur Respir J
-
-
Huppmann, P.1
Sczepanski, B.2
Boensch, M.3
Winterkmp, S.4
Schönheit-Kenn, U.5
Neurohr, C.6
-
76
-
-
84865825444
-
Stem cells and pulmonary fibrosis: Cause or cure?
-
McNulty K., Janes S.M. Stem cells and pulmonary fibrosis: Cause or cure?. Proc Am Thorac Soc 2012, 9:164-171.
-
(2012)
Proc Am Thorac Soc
, vol.9
, pp. 164-171
-
-
McNulty, K.1
Janes, S.M.2
-
77
-
-
37149052754
-
Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis
-
Serrano-Mollar A., Nacher M., Gay-Jordi G., Closa D., Xaubet A., Bulbena O. Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 2007, 176:1261-1268.
-
(2007)
Am J Respir Crit Care Med
, vol.176
, pp. 1261-1268
-
-
Serrano-Mollar, A.1
Nacher, M.2
Gay-Jordi, G.3
Closa, D.4
Xaubet, A.5
Bulbena, O.6
-
78
-
-
15944379648
-
Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis
-
Allen S., Raut S., Woollard J., Vassallo M. Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis. Palliat Med 2005, 19:128-130.
-
(2005)
Palliat Med
, vol.19
, pp. 128-130
-
-
Allen, S.1
Raut, S.2
Woollard, J.3
Vassallo, M.4
-
79
-
-
84868327008
-
Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: A randomised trial
-
Horton M.R., Santoprieto V., Mathew L., Horton K.M., Polito A.J., Liw M.C., et al. Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: A randomised trial. Ann Intern Med 2012, 157:398-406.
-
(2012)
Ann Intern Med
, vol.157
, pp. 398-406
-
-
Horton, M.R.1
Santoprieto, V.2
Mathew, L.3
Horton, K.M.4
Polito, A.J.5
Liw, M.C.6
-
80
-
-
79958268586
-
Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient
-
Egan J.J. Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient. Eur Respir Rev 2011, 20:114-117.
-
(2011)
Eur Respir Rev
, vol.20
, pp. 114-117
-
-
Egan, J.J.1
|